Karyopharm Therapeutics Inc. - Common Stock, par value $0.0001 per share (KPTI)

CUSIP: 48576U106

Q4 2013 13F Holders as of 31 Dec 2013

Type / Class
Equity / Common Stock, par value $0.0001 per share
Shares outstanding
126,468,243
Total 13F shares
9,045,141
Share change
+919,648
Total reported value
$202,954,155
Price per share
$22.92
Number of holders
53
Value change
+$20,447,000
Number of buys
2

Quarterly Holders Quick Answers

What is CUSIP 48576U106?
CUSIP 48576U106 identifies KPTI - Karyopharm Therapeutics Inc. - Common Stock, par value $0.0001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Karyopharm Therapeutics Inc. - Common Stock, par value $0.0001 per share (KPTI) as of Q4 2013

As of 31 Dec 2013, Karyopharm Therapeutics Inc. - Common Stock, par value $0.0001 per share (KPTI) was held by 53 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 9,045,141 shares. The largest 10 holders included FMR LLC, Foresite Capital Management I, LLC, Partner Fund Management, L.P., FRANKLIN RESOURCES INC, WELLINGTON MANAGEMENT CO LLP, ALLIANCEBERNSTEIN L.P., BlackRock Advisors LLC, TCW GROUP INC, BlackRock Fund Advisors, and BlackRock Institutional Trust Company, N.A.. This page lists 53 institutional shareholders reporting positions in this security for the Q4 2013 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.